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cell death
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Polycystin 2 (PC2 or TRPP1, formerly TRPP2) is a calcium-permeant Transient Receptor Potential 
(TRP) cation channel expressed primarily on the endoplasmic reticulum (ER) membrane and primary 
cilia of all cell and tissue types. Despite its ubiquitous expression throughout the body, studies of 
PC2 have focused primarily on its role in the kidney, as mutations in PC2 lead to the development of 
autosomal dominant polycystic kidney disease (ADPKD), a debilitating condition for which there is no 
cure. However, the endogenous role that PC2 plays in the regulation of general cellular homeostasis 
remains unclear. In this study, we measure how PC2 expression changes in different pathological states, 
determine that its abundance is increased under conditions of cellular stress in multiple tissues including 
human disease, and conclude that PC2-deficient cells have increased susceptibility to cell death induced 
by stress. Our results offer new insight into the normal function of PC2 as a ubiquitous stress-sensitive 
protein whose expression is up-regulated in response to cell stress to protect against pathological cell 
death in multiple diseases.
Polycystin-2 (PC2 or TRPP1, formerly TRPP2) is a Transient Receptor Potential (TRP) channel most well-known 
for its associated pathology. When mutated, PC2 causes autosomal dominant polycystic kidney disease 
(ADPKD), a debilitating condition leading to bilateral renal cyst formation and eventual kidney failure1. Located 
primarily on the endoplasmic reticulum (ER) and primary cilia of all cell and tissue types2–5, PC2 is a calcium 
(Ca2+)-permeant cation channel whose expression level directly affects Ca2+ release from the ER5. As such, PC2 
is thought to play a key role in regulating Ca2+-regulated homeostasis and signaling pathways6. This is supported 
by findings showing that polycystin-deficient cells exhibit dysregulated Ca2+ mobilization and Ca2+-regulated 
signaling pathways5,7, including pathologically increased cAMP levels8,9 and changes in mitochondrial Ca2+ 
uptake10,11. The aberrant Ca2+ signaling caused by loss of polycystins is therefore often pointed to as a central 
cause of enhanced apoptosis12,13, excess fluid secretion14,15, and metabolic abnormalities10,11,16–18 seen in cystic 
kidney cells. Given the importance of PC2 in ADPKD development, most studies of PC2 have focused on its 
function in the kidney. However, the ubiquitous expression of PC2 in all cell types suggests that it is important in 
maintaining Ca2+ homeostasis in tissues beyond the kidney.
The tight regulation of intracellular Ca2+ is necessary for many physiological functions, including protecting 
cells against outside stressors. Oxidative and ER stress responses require Ca2+ influx from both the extracellular 
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environment and intracellular stores as a key initial step for combating cell damage19–22. This elevated intracellular 
Ca2+ coordinates many physiological functions, such as changes in Ca2+-dependent gene transcription and acti-
vation of pro-survival pathways23. Because altered Ca2+ signaling occurs in cells with differential PC2 expression5, 
it follows that cells with changed PC2 levels may exhibit altered cellular homeostasis in response to stress. Indeed, 
beyond ADPKD, the polycystins have been linked to multiple extrarenal pathologies involving dysregulated 
Ca2+ and stress, including the development of liver24 and pancreatic25 cysts, cerebral aneurysms26,27, cardiac dis-
ease28, and cancer29. For instance, increased PC2 levels enhance colorectal cancer aggressiveness via modulation 
of cancer cell proliferation and migration through aberrant Ca2+-modulated signaling pathways30. Conversely, 
decreased PC2 corresponds to increased interstitial fibrosis and heightened sensitivity to injury in response to 
kidney ischemia31. It is established that the gene encoding for PC2, Pkd2, is differentially expressed during animal 
development to coordinate left-right axis determination in mice32,33 and zebrafish34. However, despite reports of 
altered PC2 expression in pathological states31,35–37, the conditions under which PC2 levels are regulated after 
development and into adulthood remain incompletely understood. Furthermore, how transcriptionally-regulated 
changes in PC2 levels influence the cellular response to stress remains unexplored. An understanding of how PC2 
levels are regulated in somatic cells will give further insight into its involvement in maintaining normal cellular 
homeostasis, and may provide potential new targets for the treatment of ADPKD and other diseases affected by 
polycystin or Ca2+ dysfunction.
Given that increased PC2 levels correlate with enhanced cell viability and proliferation30, and that elevated 
Ca2+ promotes the activation of pro-survival pathways38, we hypothesized that PC2 expression is enhanced under 
conditions of stress to help protect against cell death. In this study, we found that levels of PC2 increase in disease 
states with ER and oxidative stress. PC2 up-regulation occurred under pathological conditions in multiple tissue 
types, including the kidney, liver, brain, and hearts of both humans and animal models. Finally, PC2 knock-down 
and knock-out cells showed increased susceptibility to stress-induced cell death. Collectively, our results indicate 
that PC2 acts in all tissues as a ubiquitous stress response protein whose expression levels correlate with cell sur-
vival in response to stress.
Results
PC2 levels are increased in kidneys with acute kidney injury. As one of its main functions, PC2 
modulates intracellular Ca2+ signaling. Studies demonstrate that the expression level of PC2 directly impacts the 
amount of ER Ca2+ released in response to inositol 1,4,5-trisphosphate (InsP3)-dependent stimuli39–41. Because 
kidney tubules afflicted with ischemia-induced acute kidney injury (AKI) exhibit intracellular Ca2+ overload and 
altered Ca2+ dynamics42, we tested whether the expression level of PC2 was changed in AKI-afflicted kidneys. 
To model injury, mice were subjected to renal unilateral ischemia/reperfusion (I/R) injury with nephrectomy 
in which the right renal pedicle was clamped for 27 minutes, reperfused, then sacrificed 72 hours later and the 
right kidney collected. Left nephrectomized kidney was used as sham control (pre-injury). Increased 4-hydrox-
ynonenal (4-HNE) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), and degrada-
tion of inhibitor of kappa (IκBα) confirmed the induction of AKI in I/R kidneys compared to nephrectomy 
controls (Figs. 1A,B, S1A–C). Strikingly, PC2 abundance was also significantly increased in kidneys with I/R 
injury (Fig. 1A,C), consistent with work showing increased levels of PC2 in rat kidneys with AKI31,35. We then 
tested whether this increase was occurring transcriptionally by measuring the mRNA levels of Pkd2 in nephrec-
tomy control and AKI kidneys. We found that the kidneys afflicted with AKI had significantly higher levels of 
Pkd2 mRNA (Fig. 1D), indicating that both PC2 transcript and protein are increased with stress. To confirm the 
translational relevance of this response in humans, we performed immunofluorescent staining for PC2, collect-
ing ducts (staining for the lectin Dolichos biflorus agglutinin [DBA]), and mitochondria (staining for the volt-
age-dependent anion channel [VDAC]) in normal human kidneys (NHK) or kidneys from patients diagnosed 
with acute tubular injury (AKI; Figs. 1E, S1D; patient information included in Table S1). Quantification of PC2 
intensity per cell area revealed that, as in the murine response to AKI, PC2 was significantly increased in human 
kidney tubules with AKI (Fig. S1E).
PC2 is increased in livers with non-alcoholic fatty liver disease. Whereas kidney cyst development 
with ADPKD is well-established, pathologies caused by mutations to PKD2 do not exclusively affect the kidneys. 
The development of cysts arising from hepatic epithelial cells is a common extrarenal result of ADPKD24. Like 
cystic kidney cells, PC2-null cystic liver cells exhibit altered intracellular Ca2+ handling and changes in intracellu-
lar signaling pathways, indicating the importance of PC2 in tissues outside of the kidney43. To investigate whether 
PC2 abundance also changes in liver cells with stress, we fed mice a normal diet (ND) as control, or high-fat diet 
(HFD) to induce insulin resistance and hepatic stress44. After 8 weeks, mice were subjected to glucose tolerance 
tests, and the HFD-fed mice were found to be glucose intolerant compared to ND-fed mice (Fig. 2A,B). Livers 
from these mice were collected and showed increased levels of 4-HNE and C/EBP Homologous Protein (CHOP; 
Figs. 2C, S2A,B), indicating the induction of stress in HFD-fed mice. Immunoblotting for PC2 showed a signif-
icant increase in stressed livers from HFD-fed mice (Figs. 2C, S2C). Additionally, qPCR analysis of liver mRNA 
from mice fed ND or HFD showed a significant increase in Pkd2 mRNA in the HFD-fed mouse livers (Fig. 2D), 
demonstrating that stress-related Pkd2 up-regulation is not restricted to renal tissue.
The translational relevance of these findings was verified by performing immunofluorescent staining of 
normal human livers (NHL) and livers from patients with diet-induced non-alcoholic steatohepatitis (NASH; 
Figs. 2E, S2D; patient information included in Table S2). Quantification of PC2 fluorescence per cell area demon-
strated that human livers afflicted with non-alcoholic fatty liver disease (NAFLD) likewise have increased abun-
dance of PC2 (Fig. 2F), supporting the hypothesis that PC2 retains critical function in tissues beyond the kidney.
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PC2 is up-regulated with stress in cardiac tissue. Although the most striking symptom of ADPKD 
is the formation of bilateral renal cysts, the most common cause of death in ADPKD patients is a consequence 
of cardiac abnormalities45,46. Due to the expression of PC2 in cardiac tissue and the apparent importance of the 
polycystins in heart function, PC2 levels were examined in a murine model of cardiomyopathy and were found 
to be increased in isoproterenol (ISO)-treated hearts compared to healthy controls36. We observed that cellular 
stress was induced in the hearts of these ISO-treated mice as indicated by increased 4-HNE levels (Fig. S3A,B), 
confirming that, as in kidney and liver tissue, increased PC2 was accompanied by cellular stress in the ISO-treated 
hearts. To test whether PC2 was also transcriptionally up-regulated in the hearts of stressed mice, we compared 
mRNA levels of Pkd2 in left ventricular (LV) tissue samples from control (sham-operated) and stressed (subjected 
to transverse aortic constriction [TAC]) mice47. Unlike the ISO-treated mice, TAC mice develop cardiac hyper-
trophy induced by a physical rather than chemical stressor. Compared to sham-operated mice, LV samples from 
TAC mice showed an increase in Pkd2 mRNA (Fig. S3C), confirming that PC2 is up-regulated transcriptionally 
in stressed mouse hearts using multiple methods of stress induction.
To determine whether up-regulation of PC2 with stress is conserved in human disease, we compared levels of 
PC2 in left ventricular (LV) tissue samples from non-failing (NF) human hearts and LV samples of failing human 
hearts, obtained from patients with ischemic cardiomyopathy (ICM) or non-ischemic cardiomyopathy (NICM; 
patient information included in Table S3)48. PC2 was largely increased in the LV samples of ICM and NICM 
versus NF hearts (Figs. 3A, S3D), and levels of 4-HNE and CHOP were significantly increased in NICM hearts 
and trending toward increased in ICM samples (Fig. S3E,F). However, because these stress markers were not 
significantly increased in ICM samples, we questioned whether the up-regulation of PC2 correlated to the degree 
of stress in these heart samples. We therefore plotted the relative protein levels of PC2 versus CHOP and found a 
significant correlation between the expression of these proteins (Fig. 3B), demonstrating that although statistical 
Figure 1. PC2 levels are increased in pathologically stressed kidneys. (A) Normal (Sham) and AKI-afflicted 
mouse kidneys were immunoblotted for 4-HNE and PC2. Each band represents one biological replicate. Full-
length blots shown in Fig. S6. (B,C) Quantification of 4-HNE and PC2 protein abundance in Sham and AKI 
kidneys, normalized to actin. *p < 0.05 as determined by Mann Whitney U test. Data presented as median with 
range. Sample size n = 3 biological replicates per group. (D) Normalized mRNA expression of Pkd2 in Sham and 
AKI-afflicted mouse kidneys. Gapdh used as internal control. Sample size n = 8 biological replicates per group. 
***p < 0.001 as determined by Mann Whitney U test. Data presented as median with range. (E) Normal human 
kidneys (NHK) or kidneys with acute kidney injury (AKI) were stained for PC2 (green), DBA (red), a marker 
for collecting ducts, and VDAC (blue), an outer mitochondrial membrane protein. Scale bar, 75 μm.
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analyses of 4-HNE and CHOP levels do not show a significant increase in ICM samples, the degree of stress in 
the heart directly correlates with levels of PC2. Plotting relative PC2 versus 4-HNE levels showed a trend toward 
correlation, but this was not statistically significant due to an outlier in the NICM group (Fig. S3G).
To test if the increased PC2 seen in NICM and ICM LV tissues was due to differential gene expression, we 
compared the mRNA levels of PKD2 in these samples versus NF LV samples. Transcript levels of PKD2 were 
elevated in LV samples from ICM and NICM patients (Fig. 3C), indicating that PC2 increase with stress occurs 
via transcriptional up-regulation in human hearts. To see if there were differences in cellular stress levels asso-
ciated with increased PKD2 in the ICM and NICM failing hearts, curated lists of genes associated with cellular 
responses to ER and oxidative stress were collected from MetaCore (Clarivate Analytics) and Ingenuity Pathway 
Analysis (Ingenuity Systems, QIAGEN Bioinformatics). Genes from these lists were compiled (Tables S4 and 5, 
“Compiled”) and used to generate an expression heat map of NF, ICM, and NICM transcripts. All transcripts 
depicted in the heat map are significantly (p < 0.05) changed among the samples. Transcripts were sorted via hier-
archical clustering and demonstrate distinct differential expression patterns in the stress genes of NF compared 
to ICM and NICM samples (Fig. 3D), demonstrating that up-regulation of PKD2 correlates with altered stress 
response genes in human hearts.
Because elevated PC2 was associated with increases in canonical markers of both ER (CHOP) and oxidative 
(4-HNE) stress (Figs. 1A,B, 2C, Fig. S2A,B, Fig. 3A,B, and Fig. S3D–F), we hypothesized that PKD2 expres-
sion was changed as part of the integrated stress response (ISR) pathway, an essential adaptive pathway that 
is activated in response to both ER and oxidative stressors49–53. To explore this idea, we cross-referenced the 
compiled ER and oxidative stress gene lists to develop a more stringent list of stress-associated genes (Tables S4 
and 5, “Overlapping”), and cross-referenced these overlapping lists to identify genes involved in both responses. 
Between 11 ER stress- and 32 oxidative stress-associated genes, there were 6 genes present in both groups 
(Fig. 3E), two of which were differentially expressed in the NF versus ICM and NICM heart samples (Fig. S3H,I). 
We then used correlation analysis with a cutoff of 70% correlation or higher and discovered that one of the ISR 
genes, NFE2L2, positively correlated with PKD2 expression (Fig. 3F; correlation = 79.2%). NFE2L2, also known 
Figure 2. PC2 levels are increased in livers with NAFLD. (A) Plasma blood glucose levels and (B) quantified 
area under the curve during glucose tolerance tests of mice fed ND or HFD for 8 weeks. Shown are the mean 
area under the curve ± SD of 5 mice per group. **p < 0.01 as determined by Mann Whitney U test. (C) Mouse 
livers from ND- or HFD-fed mice were immunoblotted for PC2, 4-HNE, and CHOP. Each lane represents one 
biological replicate; sample size n = 4 per group. Full-length blots shown in Fig. S7. (D) Normalized mRNA 
expression of Pkd2 in livers of mice fed ND or HFD for 14 months. Gapdh used as internal control. Sample 
size n = 3 biological replicates per group. *p < 0.05 as determined by Mann Whitney U test. Data presented 
as median with range. (E) Normal human livers (NHL) or livers with non-alcoholic steatohepatitis (NASH) 
were stained for PC2 (green) and VDAC (red). Scale bar, 100 μm. LD = lipid droplet. Asterisks depict lipid 
accumulation within the liver. (F) PC2 intensity normalized to cell area was quantified in human NHK and 
NASH livers. ***p < 0.001 as determined Mann Whitney U test. Quantification is of 5 images per sample; 
sample number NHL n = 6, NASH n = 9.
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as Nrf2, is a transcription factor that binds the antioxidant response element (ARE) and activates the expression 
of genes involved in the response to cellular insults54–57. The other ISR gene that was changed in ICM and NICM 
samples, ATP2A2, did not pass the 70% correlation cutoff (Fig. S3J). We tested whether these correlations were 
conserved in the LV from stressed mouse hearts and discovered that, like the human hearts, stressed TAC mice 
had decreased levels of Atp2a2 (Fig. S3K) and a trend toward increased Nfe2l2 (Fig. S3L). These data suggest that, 
unlike other stress response proteins, PKD2 up-regulation is non-promiscuous and thus is directly associated 
with specific ISR pathways.
Figure 3. PC2 expression is up-regulated with stress and correlates with ISR pathway activation. (A) Left 
ventricular (LV) tissue samples from non-failing (NF) human hearts and from heart failure patients with non-
ischemic cardiomyopathy (NICM) or ischemic cardiomyopathy (ICM) were immunoblotted for PC2, 4-HNE, 
and CHOP. Each lane represents one biological replicate; data shown are representative of n = 8 for each 
condition. Full-length blots shown in Fig. S8. (B) Normalized protein expression of PC2 was plotted against 
its corresponding normalized CHOP expression. Linear regression analysis demonstrated that PC2 levels 
significantly correlated with stress induction as measured by CHOP abundance. (C) RNA-Seq RPKM values 
from human NF LV samples and in heart failure patients diagnosed with ICM or NICM were log2 transformed 
and their fold change determined. PKD2 transcripts were increased in the LV of ICM and NICM, compared 
to NF, hearts. *p < 0.05 and **p < 0.01 as determined by one-way ANOVA. Data presented as mean ± SD. (D) 
Curated lists of ER- and oxidative-stress associated genes were used to generate a heat map of stress-related 
gene expression in NF, ICM, and NICM samples. All genes shown exhibited significant differential expression 
(p < 0.05) amongst groups. A color legend is pictured with a scale from −2 to +2-fold change. (E) Genes 
that were overlapping between MetaCore and IPA-curated lists were used to generate ‘overlapping’ ER and 
‘overlapping’ oxidative stress lists. These lists were cross-referenced, and 6 genes appeared in both lists, which 
were classified as ISR pathway genes. (F) Linear regression analysis demonstrated that one of the two ISR 
genes differentially expressed amongst NF, ICM, and NICM samples, NFE2L2, significantly correlated with 
PKD2 expression. (G) Human iPSC-CMs were treated with increasing concentrations of H2O2 for 2 hours and 
immunoblotted for 4-HNE and PC2. Each lane represents one independent experiment; sample size n = 3 
independent experiments per group. Full-length blots shown in Fig. S9. (H) Quantification of PC2 abundance 
in untreated (Ctrl) versus H2O2-treated iPSC-CMs. **p < 0.01 as determined by one-way ANOVA. Data 
presented as mean ± SD.
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To then investigate whether PC2 expression increases as a direct consequence of cellular stress, we treated 
human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with increasing concentrations 
of hydrogen peroxide (H2O2) to induce cell stress in vitro. H2O2 treatment led to increased levels of oxidative 
stress in iPSC-CMs as measured by 4-HNE (Figs. 3G, S3M). Immunoblotting for PC2 levels in iPSC-CMs 
showed two distinct bands, as has been previously observed58. It is thought that the higher band depicts the 
full-length, N-glycosylated form of PC2, with the lower band depicting a potentially cleaved, inactive form of 
PC2. Quantification of full-length PC2 levels showed an increase after 2 hours of H2O2 treatment in iPSC-CMs, 
establishing that increased PC2 occurs as a direct consequence of cellular insult (Fig. 3G,H).
PC2 expression is increased in stressed brains. Having determined that PC2 abundance changes with 
stress in tissues known to rely on PC2 for proper function, we questioned whether its role as a stress-sensitive 
protein was conserved in tissues less studied in the context of PC2. Expression of PC2 in the brain led us to test 
whether its abundance is also altered with stress in the central nervous system. As a model of pathologically 
altered Ca2+ signaling and cell stress in the brain59,60, we used kainic acid to induce acute seizures in mice61. 
Systemic injections of kainate cause epileptiform seizures in the hippocampus and induce hippocampus-restricted 
neuropathology comparable to that seen in patients with temporal lobe epilepsy61. Mice were injected intraperi-
toneally with saline (Sal) or kainic acid (KA; Fig. S4A), and their seizures scored according to a modified Racine 
scale every 10 minutes for 120 minutes (Fig. 4A, Table S6). Hippocampal lysates collected from randomly-paired, 
weight- and age-matched mice were found to have increased expression of PC2 in epileptic compared to 
saline-treated brains (Fig. 4B). Pkd2 and Nfe2l2 mRNA expression was likewise tested from hippocampi of saline- 
and KA-treated mice and found to be significantly increased with KA induction of epileptic seizures (Figs. 4C, 
S4B).
We then determined whether this increase was translatable to human disease by investigating if PC2 expres-
sion correlates with stress in human brains. Using the RNA-Seq dataset provided by the Allen Institute Ivy 
Glioblastoma Atlas Project62, we examined PKD2 expression in 3 different glioblastoma structures (hyperplastic 
blood vessels, microvascular proliferation, and leading edge; patient information included in Table S7). Leading 
edge (LE) samples showed relatively low amounts of PKD2 expression, whereas hyperplastic blood vessels (HBV) 
and microvascular proliferation (MVP) samples expressed relatively high amounts of PKD2 (Fig. 4D). These 
findings correlated with differential expression of the ISR genes NFE2L2 and ATP2A2 in the different glioblas-
toma structures (Fig. S4C,D), indicating altered ISR levels amongst these structures. We then used correlation 
analysis (correlation ≥ 70%) and found that, like in human hearts, PKD2 levels positively correlated with NFE2L2 
in human brains (Fig. 4E; correlation = 76.8%), but not with ATP2A2 (Fig. S4E).
PC2 up-regulation protects cells against stress-induced cell death. Although we determined that 
PC2 expression is up-regulated as a consequence of cellular insult in multiple tissue types, whether this increase 
is detrimental or favorable for the cell remained unclear. To test this, we utilized a kidney epithelial cell line 
(LLC-PK1) with wild-type levels of PC2 (WT) or PC2 knocked down (PC2 KD; Fig. S5A) to assess PC2’s role 
in the cellular stress response. Cells were serum-starved (SS) to induce stress (Fig. S5A,B)63–65 and, consistent 
with our findings in animal and human tissues, cells showed increased PC2 mRNA and protein expression fol-
lowing serum starvation (Fig. 5A–C, S5A,C) and treatment with tunicamycin (TM), an inducer of ER stress 
(Fig. S5D–F). We then measured cell viability of WT and PC2 KD cells under basal and stressed conditions. 
When stress was induced through serum starvation or with TM treatment, PC2 KD cells showed decreased cell 
viability compared to WT cells (Figs. 5D, S5G), consistent with previous work showing that loss of PC2 renders 
kidney cells hyper-sensitive to stress31, and indicating that up-regulation of PC2 occurs as a protective mecha-
nism. To test our hypothesis that PC2 up-regulation protects against cell stress by enhancing intracellular Ca2+ 
signaling, we measured cell viability in serum-starved cells treated concurrently with the intracellular Ca2+ che-
lator BAPTA-AM. When Ca2+ signaling was blunted in SS WT cells through BAPTA-AM treatment, cell viability 
decreased to levels of SS PC2 KD cells (Fig. 5D). However, in SS KD cells treated with BAPTA-AM, there was no 
further decrease in cell viability (Figs. 5D, S5H), indicating that a PC2-dependent Ca2+ response plays a signifi-
cant role in the cells’ ability to combat stress. Finally, we measured the degree of stress-induced apoptosis through 
immunofluorescence and western blot analyses of cleaved caspase-3 activation and found that, compared to WT 
cells, PC2 KD cells had increased levels of apoptosis when stressed (Figs. 5CE,F, S5A,D,I). The same results were 
observed when testing another cell line (mIMCD-3) containing normal levels of PC2 (WT) or with PC2 knocked 
out via CRISPR/Cas9 (PC2 KO; Fig. S5J–L). These data demonstrate that PC2 up-regulation serves to protect 
cells against stress, and that with inadequate levels of PC2, cells are rendered hyper-susceptible to stress-induced 
cell death.
Discussion
In this study, we establish that PC2 is a stress-responsive protein whose expression is elevated in a variety of cell 
types under multiple pathological conditions. Its up-regulation is a direct consequence of ER and oxidative stress, 
and its mRNA expression significantly correlates with Nfe2l2, a transcription factor that is part of the ISR path-
way66. Loss of PC2 resulted in a Ca2+-mediated decrease in cell viability in response to stress and increased levels 
of stress-induced apoptosis. Collectively, these findings demonstrate that PC2 plays an important role in general 
cell homeostasis in numerous tissue types, and that up-regulation of PC2 helps protect cells against stress-induced 
cell death under pathological conditions.
The importance of PC2 in the maintenance of cellular homeostasis is well-supported by the pathological 
dysfunctions that occur in cystic ADPKD cells. Our findings indicate that PC2 is increased transcriptionally with 
cell stress, and that this occurs in response to specific signaling pathways. The function of PC2 as a modulator of 
Ca2+ signaling fits well with these findings, as Ca2+ mobilization is a critical step in the cell’s ability to respond 
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to and protect against pathological stressors. As our data indicate, enhanced Ca2+ signaling facilitated by PC2 
following cell stress contributes significantly to the cell’s adaptive response, whereas blunted Ca2+ through intra-
cellular chelation or the absence of PC2 causes hypersensitivity of the cells to outside stressors. Though changes 
in PC2 levels have been noted in different pathological conditions, the causes for its differential expression after 
development remained incompletely explored. In support of our findings, previous studies have shown that both 
Pkd2 transcript and protein levels are increased in kidneys following ischemia/reperfusion injury, and that mice 
with decreased levels of PC2 are more sensitive to injury in both kidney and smooth muscle cells31,67–69. The 
correlation we discovered between PKD2 and NFE2L2 levels suggests that PKD2 may be up-regulated via Nrf2, 
a transcription factor that is increased following cellular insults including oxidative stress70. Much of what is 
known regarding the transcriptional regulation of Pkd2 is based upon its cis-acting promoter region, which con-
tains putative binding sites for developmentally-regulated transcription factors such as Sp1, NF-1, and AP-271,72. 
However, trans-regulatory effects on Pkd2 expression have not been described and may contain additional regu-
latory elements to alter PC2 levels.
Figure 4. PC2 is increased in stressed brains. Mice were given injections of saline (Sal) or kainic acid (KA) to 
induce epileptic seizures and oxidative stress in the brain. (A) Seizure scores following injections were measured 
according to a modified Racine scale. Data shown are mean ± SD of 6 mice per group. (B) TOP: Hippocampal 
tissue was collected and immunoblotted for PC2 24 hours following injections. Each lane represents one 
biological replicate; sample size n = 6 per group. Full-length blots shown in Fig. S11. BOTTOM: Quantification 
of PC2 protein abundance in Saline and KA-treated hippocampi, normalized to actin. *p < 0.05 as determined 
by Mann Whitney U test. Data presented as median with range. Sample size n = 6 biological replicates per 
group. (C) Normalized mRNA expression of Pkd2 in hippocampi from mice injected with saline or KA. Gapdh 
used as internal control. Sample number Saline n = 6, KA n = 5. **p < 0.01 as determined by Mann Whitney 
U test. Data presented as median with range. (D) RNA-Seq FPKM values from different structures (LE, leading 
edge; HBV, hyperplastic blood vessel; MVP, microvascular proliferation) of human glioblastoma samples were 
log2 transformed and their fold change determined. PKD2 transcripts were increased in HBV and MVP samples 
compared to LE. ****p < 0.0001 as determined by one-way ANOVA. Data presented as mean ± SD. (E) Linear 
regression analysis demonstrated that the ISR gene NFE2L2 significantly correlates with PKD2 in human 
glioblastoma tissues.
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Our results demonstrate that PC2 KD and KO renders cells susceptible to stress-induced death. It therefore 
logically follows that cystic cells characterized by loss the of PC2 would exhibit decreased cell viability in response 
to stress. In support of this, a standard phenotype associated with ADPKD is enhanced apoptosis during cyst 
development69,73,74, where cellular stress levels are high due to many pathological factors, including renal ischemia 
Figure 5. PC2 protects against stress-induced cell death. (A) Kidney epithelial LLC-PK1 cells were grown 
in normal culture medium (Control) or base medium not supplemented with FBS (Serum Starved, SS) for 
24 hours, then stained for DAPI (blue), phalloidin (red), and PC2 (cyan). Scale bar, 25 μm. (B) PC2 intensity 
normalized to cell area was quantified in control and serum-starved (SS) LLC-PK1 cells. **p < 0.01 as 
determined by Mann Whitney U test. Quantification is of 5 images per sample; n = 10 samples per group. 
Data presented as median with range. (C) Fold change mRNA expression of Pkd2 in serum-starved WT, and 
control and serum-starved PC2 KD cells compared to WT control cells. Actin used as internal control. n = 3 
independent experiments per group. ***p < 0.001 as determined by one-way ANOVA. Data presented as 
mean ± SD. (D) Viability of WT and PC2 KD (KD) cells was tested via CellTiter-Glo assay under normal (Ctrl) 
and stressed (SS) conditions with or without 24-hour co-treatment of 100 nM BAPTA-AM (BAPTA). *p < 0.05, 
**p < 0.01, and ****p < 0.0001 as determined by one-way ANOVA. n = 3 independent experiments per group 
with 10 replicates per experiment. Data presented as mean ± SD. (E) WT and PC2 KD cells were grown in 
normal culture medium (Ctrl) or serum starved (SS) for 24 hours, then stained for DAPI (blue) and cleaved 
caspase 3 (green). Images shown are representative of 10 control and 10 serum-starved samples from both WT 
and PC2 KO cell lines. Scale bar, 25 μm. (F) Cleaved caspase 3 intensity normalized to cell area was quantified. 
***p < 0.001 and ****p < 0.0001 as determined by one-way ANOVA. Quantification is of 5 images per sample; 
n = 10 samples per group. Data presented as mean ± SD.
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and altered cell metabolism. In fact, treatment of ADPKD mice with caspase inhibitors (inhibitors of apoptosis) 
results in decreased cyst volume and cell proliferation74. Additionally, PC2 haploinsufficient (Pkd2+/-) kidney cells 
that express decreased overall levels of PC2 show hypersensitivity to cell stress. Pkd2+/- mice develop larger, more 
pronounced kidney cysts when treated with Tumor Necrosis Factor alpha (TNFα, an inflammatory cytokine) 
to induce stress as compared to wild-type littermates, whereas treatment of Pkd2+/- mice with TNFα inhibitor 
blocked cyst formation75. Additional studies seeking effective treatment for kidney disease have identified resver-
atrol, a potent activator of Nrf276, as a potentially compelling therapeutic agent for slowing cyst progression in 
ADPKD77,78. Whereas these studies have focused on the effects of resveratrol in ameliorating the inflammatory 
response associated with cyst development, it is possible that resveratrol may act through Nrf2 to help restore 
normal ISR activity in these cells as well.
Although renal cyst formation and kidney failure are arguably the most well-known symptoms of PC2 
dysfunction, multiple extrarenal pathologies are also known to occur in patients with loss-of-function PKD2 
mutations. Indeed, ADPKD patients commonly present with numerous manifestations of the disease, includ-
ing colonic diverticula79,80, hernia81,82, cerebral aneurisms83, and the development of hepatic84, pancreatic25, and 
seminal vesicle85,86 cysts. Most notably, however, rather than renal failure, the major cause of death in patients 
with ADPKD is due to cardiac dysfunction83. Studies seeking to elucidate how the loss of PC2 affects the heart 
have shown that with increased age, decreased PC2 levels result in cardiac dysfunction independent of renal 
abnormalities87. Additionally, in agreement with our findings, PC2 levels are enhanced in cardiomyocytes with 
cardiac injury, and Pkd2+/- mice show a diminished capacity to recover from injury following the cessation of 
stress36. It has been suggested that the extrarenal manifestations seen in ADPKD patients are merely secondary 
effects caused by the main pathology of renal cysts. However, our findings highlight the importance of PC2 as a 
ubiquitous protein essential for proper cell function not only in the kidney, but in all tissue types. Based on this, 
the role of PC2 in numerous Ca2+-associated stress pathologies may prove to be a promising target by which to 
restore normal Ca2+ and/or ISR homeostasis.
Our in vitro data suggest that PC2 regulation of Ca2+ signaling is required to maintain cell viability in the face 
of stress. Whereas the function of PC2 as a Ca2+-permeable cation channel is well-established, there currently 
exists controversy over where PC2 exerts its intrinsic channel function. It is thought that due to the ER retention 
signal within its C-terminal tail, the majority of PC2 is located on the ER5,88, with the rest being localized to the 
primary cilia in association with PC189 or TRPV490, where it exerts its anti-cystogenic function91. However, others 
have suggested that PC2 is also present and functions as a Ca2+ channel on the plasma membrane92,93. In the con-
text of our findings, we believe that PC2 exerts its stress response function from its localization on the ER based 
upon (1) immunofluorescent imaging demonstrating that PC2 localization remains intracellular, even under 
stressed conditions (Figs. S1D and S2D) and (2) the up-regulation of PC2 with stress in terminally-differentiated 
neurons and cardiomyocytes, whose cilia are stumpy, essentially vestigial organelles. Nevertheless, the localiza-
tion of PC2 does not ultimately influence the findings of this manuscript, as PC2 is believed to facilitate enhanced 
cytoplasmic Ca2+ signaling whether functioning on the ER, primary cilia, or plasma membrane.
Additionally, though PC2 is itself can form a Ca2+-permeable cation channel, it is known to interact with other 
cation channels to enhance intracellular Ca2+ signaling (including the inositol 1,4,5-trisphosphate receptor39,40,94, 
ryanodine receptor95, and other TRP channels90,96). Therefore, whether PC2 is altering intracellular Ca2+ signaling 
through its intrinsic channel activity or through interactions with other channels remains unclear. Interestingly, 
PC2 channel activity has been shown to be sensitive to H2O2, whose treatment caused an up-regulation of PC2 
in human iPSC-CMs. Because the reported IC50 of this inhibition is ~193 μM97, we do not believe that the H2O2 
concentration used in our experiment (up to 200 μM) would be sufficient to completely eliminate a Ca2+ cur-
rent through PC2. Nonetheless, if it were the case that PC2 is fully inhibited with stress, our data showing that 
BAPTA-AM treatment (Fig. 5D) in PC2 KD cells has no effect on cell viability compared to WT cells demon-
strates the requirement for PC2-mediated Ca2+ signaling in the response to cell stress, whether this is through 
PC2’s intrinsic channel activity or its interactions with other channels.
Our study is limited by the variability of sample size throughout the different types of tissues and stress. For 
all conditions, we tested at least n = 3 samples to ensure that proper statistics could be performed during analy-
ses. When possible, we maximized the sample size to increase the power of our study. However, the sample size 
of human and mouse tissues varied depending upon availability. Variables affecting this included limited access 
to human pathological samples with specific diagnoses, and the survival of mice undergoing stress procedures. 
Additionally, though our data point to a potential link between PKD2 and NFE2L2 expression, we do not pre-
sume to state that NFE2L2 directly causes PKD2 up-regulation based on our results. Rather, our data show that 
PKD2 expression correlates with the activation of the ISR pathway due to its role as a stress response protein. The 
possibility remains that 1) increased Nrf2 may influence PKD2 expression directly, 2) NFE2L2 transcription may 
be increased due to altered signaling in cells with increased PC2, 3) PKD2 and NFE2L2 are up-regulated under 
similar stress conditions, but neither one directly affects the expression of the other, or 4) increased PKD2 mRNA 
is independent of its transcription, but rather is a consequence of post-transcriptional changes such as mRNA 
stability. Consequently, if and how PC2 and Nrf2 influence one another’s expression, along with the exact mech-
anism of increased PKD2 transcript will require further in-depth mechanistic studies.
Collectively, we describe a new functional role for PC2 as a stress-sensitive protein that is up-regulated in 
response to cellular insults in multiple disease states and tissue types. Moreover, loss of PC2 is sufficient to render 
cells hypersusceptible to stress-induced cell death, implicating altered stress response pathways in the develop-
ment of polycystin-related pathologies. The ubiquitous expression of PC2 throughout the body raises the possi-
bility that PC2 may contribute to disease states in other tissues where the ISR is induced or disrupted, and may 
provide a novel target to help ameliorate the progression of these diseases.
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Materials and Methods
Reagents and antibodies. Anti-PC2 (sc-47734; for immunoblotting), anti-NFκB (sc-8008), and anti-IκBα 
(sc-1643) antibodies were purchased from Santa Cruz Biotechnology. Anti-PC2 antibody for immunofluorescent 
imaging was a kind gift from Dr. Stefan Somlo (Yale). Mouse anti-beta-Actin (#3700), rabbit anti-beta-Actin 
(#4970), anti-CHOP (#2895), anti-cleaved caspase-3 (#9664), and anti-GAPDH (#2118) antibodies were pur-
chased from Cell Signaling Technology. Anti-4-Hydroxynonenal (ab48506), anti-eIF2α (ab50733), anti-phospho-
eIF2α (ab32157) antibodies, and kainic acid (ab120100) were purchased from Abcam. Anti-VDAC (PA1-954A) 
antibody was purchased from Thermo Fisher Scientific. Hydrogen peroxide (H325-100) and BAPTA-AM 
(B1205) were purchased from Thermo Fisher Scientific. Tunicamycin (T7765), and Dimethyl sulfoxide (DMSO; 
W387520) were purchased from Sigma-Aldrich.
Animal studies. The Yale University and University of Illinois at Urbana-Champaign Institutional Animal 
Care and Use Committees (IACUC) approved the animal housing conditions and the experimental procedures 
conducted in this study. All experiments were performed in accordance with relevant guidelines and regula-
tions. C57BL/6 mice were kept under standard laboratory conditions with free access to food and water. Control 
mice were provided 2018S Teklad global rodent diet (Envigo). For diet-induced obesity, mice were fed TD.06414 
Teklad diet containing 60% kcal/fat (Envigo) for 8 weeks-14 months, as described in the figure legends, beginning 
at 10 weeks of age. All animal experiments were performed in a blinded manner.
Renal ischemia/reperfusion mouse model. Male 8- to 10-week-old C57BL/6 mice (National Institutes 
of Health/National Cancer Institute) were anesthetized with i.p. ketamine (100 mg/kg) and xylazine (10 mg/kg) 
then subjected to renal ischemia reperfusion (I/R) using a modified approach of that described previously98. 
Briefly, the right renal pedicle was isolated through a midline abdominal incision and clamped for 27 minutes 
using a nontraumatic microaneurysm clip (B-2, Fine Science Tools). The left kidney was removed and collected 
immediately before I/R of the right kidney (Sham, nephrectomized kidney). Mice were kept at 37 °C at all times 
during the procedure, and reperfusion of kidneys was confirmed after clamp release. Mice were given 1 ml normal 
saline intraperitoneally to prevent dehydration and were euthanized 72 hours after I/R. Kidney tissue was har-
vested for immunoblotting as described below.
Glucose tolerance testing. At 18 weeks of age, mice were fasted for 16 hours before glucose tolerance 
testing. Glucose was administered via i.p. injection (1.5 g/kg body weight). Blood glucose measurements were 
taken immediately before injection and at 15, 30, 60, and 120 minutes following injection. Blood was collected 
using a lateral tail nick and glucose levels were measured using blood glucose strips and OneTouch glucometer 
(LifeScan).
Kainic acid-induced acute seizure mouse model. At 8–10 weeks of age, male C57BL/6 J mice (Jackson 
Laboratory, Stock Number: 000664) received an i.p. injection of kainic acid (30 mg/kg body weight) or an equal 
volume of 0.9% saline as described99. Mice were returned to their cages and monitored for behavioral seizures 
every 10 minutes for 2 hours following injection. Behavioral seizures were scored according to a modified Racine 
scale as described previously100,101. At 24 hours post injection, mice were euthanized by CO2 inhalation and brains 
stored at −80 °C until use.
Brain lysate preparation. The dissected brain regions per mouse were homogenized in ice-cold homog-
enization buffer (Solution A) containing (in mM): 320 sucrose, 1 NaHCO3, 1 MgCl2, 0.5 CaCl2, 0.4 HEPES (pH 
7.4) and Halt protease inhibitors (Thermo Fisher Scientific) as previously described99. After centrifuging at 1400 
x g for 10 minutes at 4 °C, the homogenate supernatant (S1) was separated from insoluble tissue and nuclear 
pellet (P1). The S1 fraction was then centrifuged at 13,800 x g for 10 min at 4 °C. The supernatant with cytosolic 
soluble proteins (S2) was removed, and the remaining pellet with transmembrane proteins and membrane-bound 
proteins (P2 membrane fraction) was resuspended in ice-cold solution B containing (in mM): 160 sucrose, 6 
Tris-HCl, 0.5% Triton-X (pH 8.0) and Halt protease inhibitors. Pierce BCA assay (Thermo Fisher Scientific) was 
performed to normalize protein concentrations to 1 mg/ml in Solution B (pH 7.4). The S1, S2, and P2 fractions 
were stored at −80 °C until use.
Western blot. Lysates of mouse kidneys, hearts, livers and human hearts were prepared by homogenization 
in radioimmunoprecipitation assay (RIPA) buffer containing SDS (Santa Cruz Biotechnology) with Halt protease 
and phosphatase inhibitor cocktail (Thermo Fisher). Lysates of mouse hippocampi were prepared as described 
above and the P2 fractions were run for western blotting. Cultured cells were lysed directly in M-PER mammalian 
protein extraction reagent (Thermo Fisher) supplemented with Halt protease and phosphatase inhibitor cocktail. 
Equal amounts of protein were loaded, and electrophoresis was performed in NuPAGE 4–12% gradient bis-tris 
polyacrylamide protein gels (Thermo Fisher). Proteins were transferred to PVDF membrane and blocked with 
5% milk in phosphate-buffered saline with Tween-20 for 1 hour. Membranes were then incubated overnight with 
primary antibody at 4 °C. Blots were washed and incubated with secondary antibody for 1 hour at room tempera-
ture. After washing, the secondary antibody was visualized by Pierce ECL chemiluminescence reagents (Thermo 
Fisher) or using a LI-COR Odyssey imaging system (LI-COR Biosciences).
Human tissue. Human kidney and liver tissues were identified and obtained through the Department of 
Pathology at the Yale School of Medicine. All experimental protocols and the use of these tissues for research 
were approved by the Yale Institutional Review Board. All methods were carried out in accordance with rel-
evant guidelines and regulations. Informed consent was obtained from all subjects donating samples. Tissues 
were fixed with 4% paraformaldehyde at 4 °C overnight, embedded in paraffin, and 5 μm sections were cut for 
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immunofluorescence. Following deparaffinization and rehydration, antigen retrieval was performed by incubat-
ing the sections in a steamer for 20 min in sodium citrate buffer (10 mM Tri-sodium citrate, 0.05% Tween-20, pH 
6.0). Sections were then quenched of autofluorescence, blocked and permeabilized, and incubated with anti-PC2 
(Santa Cruz Biotechnology), anti-lectin Dolichos biflorus agglutinin (DBA; Vector Laboratories), and anti-VDAC 
(Cell Signaling) antibodies. Tissues were mounted in ProLong Gold Antifade Mountant (Life Technologies) and 
imaged with 40× and 100× oil-immersion lenses on a Leica SP8 gated STED Microscope using Leica LAS X soft-
ware (Heidelberg, Germany). To enable comparison among samples, the same laser power, gain and acquisition 
settings were used across all slides.
Immunofluorescence. LLC-PK1 and mIMCD3 cells were immunostained as described previously41. Briefly, 
cells were plated on poly-L-lysine-coated glass coverslips and fixed with 4% paraformaldehyde for 10 minutes 
at 37 °C. After blocking in 2% BSA and 0.2% Triton X-100, cells were incubated in the same solution with pri-
mary antibody for active caspase 3 and PC2 overnight at 4 °C, then incubated in anti-rabbit AlexaFluor 488 
(Life Technologies), phalloidin conjugated to tetramethylrhodamine (TRITC; Life Technologies), and anti-mouse 
AlexaFluor 633 (Life Technologies) for 1 hour before mounting with ProLong Gold antifade mounting reagent 
with DAPI (Life Technologies). Slides were imaged with a Leica TCS SP5 Confocal Laser Scanning Microscope.
To calculate PC2 and Cleaved Caspase 3 intensity, ImageJ (NIH) was used for image processing. All meas-
urements of fluorescence intensity were calculated using images taken at 10X magnification to ensure unbiased 
and robust quantification. Individual cells or cell groups were selected as regions of interest (ROIs,) and the flu-
orescence intensity and area were calculated for each ROI. Intensity was divided by its corresponding area and 
averaged across each image. Five images were taken per condition and averaged to plot as Intensity/Area.
Human heart RNA-Seq. RNA Sequencing was performed on left ventricular tissue samples from 
non-failing (NF; n = 8) human donor hearts, and from failing human hearts obtained from patients with ischemic 
cardiomyopathy (ICM; n = 8) or non-ischemic cardiomyopathy (NICM; n = 8) as described previously48. Data 
were analyzed using Qlucore Omics Explorer (Lund, Sweden). Normalized Reads Per Kilobase of transcript, per 
Million mapped reads (RPKM) values were log2 transformed and fold change calculated. Curated lists of genes 
associated with cellular responses to ER and oxidative stress were collected and cross-referenced from MetaCore 
(Clarivate Analytics) and Ingenuity Pathway Analysis (Ingenuity Systems, QIAGEN Bioinformatics). The genes 
were compiled and used to generate an expression heat map of differentially regulated (p < 0.05) ER and oxida-
tive stress-related genes. Linear regression analysis was performed to show significant (p < 0.0001) correlation 
between PKD2 and NFE2L2 transcripts.
iPSC culture and differentiation. Human induced pluripotent stem cells (iPSC) were acquired from the 
Coriell Institute (GM23338), as characterized previously102. iPSC colonies were maintained on growth-factor 
reduced Matrigel (Corning)-coated tissue culture plates in mTeSR1 medium (Stem Cell Technologies). iPSCs 
were differentiated into iPSC-derived cardiomyocytes (iPSC-CMs) following a sequential protocol of manipu-
lating the WNT pathway103, using 12.5 μM CHIR99021 (Stem Cell Technologies) for 24 hours and 5 μM IWP4 
(Tocris Bioscience) for 48 hours on day 3 after the induction of differentiation. Subsequently, the differentiating 
cultures were maintained in RPMI + B2-insulin until day 11 when spontaneous beating was observed. Media 
was then changed to RPMI + B27 + insulin for 2 days, followed by 4 days of metabolic selection using DMEM 
without glucose and 4 mM lactate104. iPSC-CMs were kept in RPMI + B27 + insulin until day 21 after the start 
of differentiation when they were dissociated and re-plated on a 12-well plate coated with 50 μg/ml fibronectin 
(bovine, Sigma-Aldrich)105. iPSC-CMs were cultured for a subsequent 2 days in RPMI + B27 + insulin before 
experiments were performed.
Human glioblastoma project RNA-Seq. The open-source RNA-Seq dataset from The Allen Institute’s 
human glioblastoma project was used to interrogate the relationship between PKD2 expression in human brain 
and integrated stress response genes. RNA-Seq was performed on different glioblastoma structures as described62 
and the FPKM values log2 normalized before analysis with Qlucore Omics Explorer. Linear regression analysis 
was performed to show significant (p < 0.0001) correlation between PKD2 and NFE2L2 transcripts.
Creation of stable knockdown cells. Short hairpin RNA (shRNA) against Pkd2 was designed to be spe-
cific to the pig sequence. The previously described41,106 PC2 shRNA constructs were put into a psiRNA vec-
tor (InvivoGen, San Diego, CA), which was stably transfected into LLC-PK1 cells. Cells were exposed to G418 
(2.5 mg/ml) as previously described41,106. LLC-PK1 cells were maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and kept at 37 C in 5% CO2.
In vitro stress treatment. Cells were plated on a 6-well plate (Corning) at a density of 400,000 cells per well. 
The following day, cells were either treated with the commonly used ER-stress inducer Tunicamycin (TM)107 or 
serum-starved for 24 hours. After treatment, the cells were lysed and collected as described above for Western 
Blot or stained for Immunofluorescence.
Measurement of cellular stress. To assess the level of cellular stress in both in vivo and in vitro sam-
ples, we immunoblotted for several markers whose levels are changed in response to stress: 4-HNE, a reactive 
short-chain aldehyde formed during lipid peroxidation following oxidative stress108; CHOP, a protein involved in 
ER-stress mediated apoptosis51; eIF2α, whose phosphorylation (p-EIF2α) is the core event in the integrated stress 
response pathway50; cleaved caspase 3, a commonly used marker for apoptotic cells109.
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mRNA analysis. mRNA was extracted from animal tissue and cultured cells using a RNeasy RNA Isolation 
Kit (Qiagen, Hilden, Germany) and reverse-transcribed to complementary DNA (cDNA) using Multiscribe 
Reverse Transcriptase and random primers (Applied Biosystems, Foster City, CA). For real-time quantita-
tive PCR, 20 ng of cDNA was used as transcript template in a reaction with Power SYBR Green Master Mix 
(Applied Biosystems) on a 7500 Fast Real-Time PCR system (Applied Biosystems). Fold change in Pkd2 (Fwd 
5′—CAGAGGGGCTGCTACAGTTT—3′; Rev 5′—TTGAAGAGCTTAATCCAGACCA—3′) and Nfe2l2 
(Fwd 5′—AGATGACCATGAGTCGCTTGC—3′; Rev 5′—CCTGATGAGGGGCAGTGAAG—3′) mRNA 
transcript levels compared to control samples were determined using the 2−(ΔΔCT) method. Actin (Fwd 5′—
GTGACGTTGACATCCGTAAAGA—3′; Rev 5′—GCCGGACTCATCGTACTCC—3′) or Gapdh (Fwd 5′—
AGGTCGGTGTGAACGGATTTG—3′; Rev 5′—GGGGTCGTTGATGGCAACA—3′) were used as internal 
control.
CellTiter-Glo assay. Cells were plated at a density of 1000 cells per well on a 96-well plate (Corning) and 
treated the following day. After 24 hours of treatment, CellTiter-Glo Luminescent Cell Viability assays were car-
ried out according to the manufacturer’s instructions (Promega Corporation). Experiments were performed in 
triplicates with 10 replicates per experiment.
Statistical analysis. For cell-based experiments, data were calculated from at least three separate prepara-
tions. For animal-based experiments, data were calculated from at least three biological replicates. Where appro-
priate, one-way analysis of variance (ANOVA) with multiple comparisons or non-parametric Mann Whitney 
U test was applied. Data are presented as (1) mean ± SD, or (2) median with range, as stated in the figure leg-
end. In all experiments, p < 0.05 was considered statistically significant. *p < 0.05, **p < 0.01, ***p < 0.001, and 
****p < 0.0001.
Data availability
The data generated, used, and/or analyzed in the current study are available from the corresponding author upon 
reasonable request.
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